Anocca Alternatives & Competitors
12 companies similar to Anocca — Engineered Immunity
Companies similar to Anocca
Tmunity Therapeutics
Pioneering the future of immunotherapy through innovative T cell engineering to tackle a d...
Gritstone bio
A lean biotech company aiming to develop revolutionary immune-based treatment for various...
Emeryville, United States
Precigen
Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of ge...
Germantown, United States
Poseida Therapeutics, Inc.
A Member of the Roche Group
San Diego, United States
Rival Readout
Competing with Anocca? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Celsius Therapeutics
On a quest to leverage the power of single cell genomics to discover novel drug targets an...
Cambridge, United States
CERo Therapeutics, Inc.
Tumor Cell Clearance Reimagined.
South San Francisco, Unit...
Hansa Biopharma
We are dedicated to bring innovative treatments to people living with rare immunological d...
Lund, Sweden
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
-Biotech,-LLC.-logo.jpg "Hangzhou ImmuQuad(艾沐蒽) Biotech, LLC."){kind=logo}
Hangzhou ImmuQuad(艾沐蒽) Biotech, LLC.
杭州艾沐蒽生物科技有限公司
Hangzhou, China
Altheia Science
Altheia Science develops treatments for autoimmune diseases and cancer using innovative to...
Milano, Italy
TC BioPharm
Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP
United Kingdom
About Anocca
Anocca, founded in 2014 and headquartered in Sweden, is making significant strides in the Biotechnology and Health Care industries with its pioneering approach to Engineered Immunity. The company is a fully integrated biopharmaceutical entity that focuses on developing T-cell receptor-engineered T cell (TCR-T) therapie...
Development of TCR-T cell therapies, Creation of precision immunotherapies, Biotechnological innovation, Disease target analysis
Pharmaceutical companies, Biotechnology firms, Oncology researchers, Healthcare providers focusing on cancer treatment
TCR-T Cell Therapy, Solid Tumours Treatment, Infectious Diseases Treatment, Autoimmune Diseases Treatment, Immunotherapy, Gene Editing Technology, CGMP Manufacturing, Biopharmaceuticals, Drug Discovery, Drug Development, T-cell Biology Analysis, Personalised Medicine, Immuno-oncology, AnoccaOS Software Ecosystem, Non-viral Gene Editing
B2B, Platform, B2B2C
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Anocca: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Anocca on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
